Curanex PharmaceuticalsCommon Stock Total Liabilities

Curanex PharmaceuticalsCommon Stock (CURX) currently reports a total liabilities of $290K as of June 2026. That compares with $480K in the prior-year period — down 40.6% year over year. Use the charts on this page to explore Curanex PharmaceuticalsCommon Stock's total liabilities history and peer comparisons.

Curanex PharmaceuticalsCommon Stock's total liabilities decreased from $480K to $290K — a 40.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Curanex PharmaceuticalsCommon Stock reported $290K in total liabilities as of June 2026. That compares with $480K in the prior-year period — down 40.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $290K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Curanex PharmaceuticalsCommon Stock, and consider following CURX for alerts when major investors trade the stock.

Curanex PharmaceuticalsCommon Stock is classified in the Healthcare sector. On total liabilities, it currently shows $290K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CURX with unrelated industries.